Skip to Content

Agilent Technologies Inc A

Morningstar Rating
$137.32 +2.34 (1.73%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Agilent Looking Forward to Macro Conditions Improving in Late 2024

Agilent focuses on providing tools to analyze the structural properties of various chemicals, molecules, and cells. The company is one of the leading providers of chromatography and mass spectrometry tools, which have applications in a variety of end markets, including the healthcare, chemical, food, and environmental fields. While healthcare-related applications, including clinical diagnostics, remain Agilent’s largest end market, Agilent generates about half of its sales from nonhealthcare fields.

Price vs Fair Value

A is trading at a 546% premium.
Price
$137.32
Fair Value
$888.00
Uncertainty
Medium
1-Star Price
$766.68
5-Star Price
$779.80
Economic Moat
Wnhs
Capital Allocation
Rgxxjqmmlz

Bulls Say, Bears Say

Bulls

Agilent's innovation engine and cost control efforts have been on display through strong growth and margin expansion since spinning out its electronic measurement business Keysight in November 2014.

Bears

Due to its dependence on one-time sales and its exposure to some cyclical end markets, Agilent's financial results may weaken during uncertain times.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if A is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$134.98
Day Range
$136.08140.29
52-Week Range
$96.80155.35
Bid/Ask
$133.73 / $141.07
Market Cap
$40.06 Bil
Volume/Avg
1.7 Mil / 2.0 Mil

Key Statistics

Price/Earnings (Normalized)
25.86
Price/Sales
6.14
Dividend Yield (Trailing)
0.68%
Dividend Yield (Forward)
0.69%
Total Yield
2.29%

Company Profile

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Core
Total Number of Employees
17,600

Competitors

Valuation

Metric
A
WAT
TMO
Price/Earnings (Normalized)
25.8627.0628.08
Price/Book Value
6.4415.014.89
Price/Sales
6.146.485.53
Price/Cash Flow
21.6422.8627.23
Price/Earnings
A
WAT
TMO

Financial Strength

Metric
A
WAT
TMO
Quick Ratio
1.491.391.19
Current Ratio
2.152.221.70
Interest Coverage
15.348.284.83
Quick Ratio
A
WAT
TMO

Profitability

Metric
A
WAT
TMO
Return on Assets (Normalized)
14.45%17.19%8.69%
Return on Equity (Normalized)
26.40%88.59%18.71%
Return on Invested Capital (Normalized)
18.41%25.75%10.97%
Return on Assets
A
WAT
TMO
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
KrrjyvvfvRjs$231.8 Bil
Danaher Corp
DHR
NwxgdpytbPzflqs$197.8 Bil
IQVIA Holdings Inc
IQV
KtddhmgdRsjzccw$43.7 Bil
IDEXX Laboratories Inc
IDXX
YgxnjqdlxHprvzbk$38.8 Bil
Mettler-Toledo International Inc
MTD
KkjqqdrtzKnqkcl$31.0 Bil
Icon PLC
ICLR
RsgxbgsvxVtcdvtt$26.8 Bil
Illumina Inc
ILMN
YkffcpczQbscck$19.2 Bil
Waters Corp
WAT
VdhxgwznYcmz$18.9 Bil
Labcorp Holdings Inc
LH
WvkgsqbdSkqms$17.8 Bil

Sponsor Center